Elora Therapeutics is developing engineered enzyme therapeutics to remove microplastics from the human body, starting with polyethylene terephthalate (PET) microplastics implicated in cancer progression and metastasis.

Our lead program uses enzymes engineered to degrade PET microplastics, a common synthetic polymer detected in human blood and tissues. Elora is initially focused on systemic PET microplastic removal in cancer progression and metastasis-relevant biology, with colorectal cancer as a focused oncology beachhead. Over time, we plan to expand across additional polymers, delivery modalities, and microplastic-linked diseases.

We are building a new therapeutic category: enzyme medicines for microplastic-associated disease.

Elora Therapeutics

Org chart

Teams

Offices

Elora Therapeutics

Org chart

Teams

Offices

Related companies